Company profile for Five Prime Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a publicly traded, clinical-stage biotechnology company focused on discovering and developing innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in im...
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a publicly traded, clinical-stage biotechnology company focused on discovering and developing innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area with significant therapeutic potential and a growing focus of the company's R&D activities.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
111 Oyster Point Boulevard South San Francisco, CA 94080
Telephone
Telephone
415-365-5600
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/five-prime-trial-investigator-pleads-guilty-to-134k-insider-trading-scheme-faces-up-to-25-years-in-prison/

P. Schloesser ENDPTS
13 Apr 2022

https://endpts.com/five-prime-trial-investigator-pleads-guilty-to-134k-insider-trading-scheme-faces-up-to-25-years-in-prison/

Paul Schloesser ENDPTS
12 Apr 2022

https://endpts.com/doj-charges-former-five-prime-trialist-with-securities-fraud-after-134k-in-insider-trading-profits/

Z. Brennan ENDPTS
22 Dec 2021

https://endpts.com/five-prime-founder-rusty-williams-sets-out-to-test-the-limits-of-cell-therapy-with-axolotl-inspired-biotech/

ENDPTS
13 Sep 2021

https://investors.amgen.com/news-releases/news-release-details/amgen-successfully-completes-acquisition-five-prime-therapeutics

PRESS RELEASE
17 Apr 2021

https://investors.amgen.com/news-releases/news-release-details/amgen-successfully-completes-acquisition-five-prime-therapeutics

PRESS RELEASE
16 Apr 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty